| Financial Year |
March 31 2023 |
| Monetary Funds |
825,138,857.54 |
| Held-for-trading Financial Assets |
166,595,657.48 |
| Notes Receivable |
-- |
| Accounts Receivable |
319,505,701.21 |
| Advances to Suppliers |
20,138,202.91 |
| Other Receivables |
1,527,803.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
712,471,805.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
710,840,132.34 |
| Total Current Assets |
2,756,418,160.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
919,087.44 |
| Investment Properties |
-- |
| Fixed Assetes |
1,289,974,692.61 |
| Under-construction Projects |
407,911,935.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,628,679.18 |
| R&D expenses |
-- |
| Goodwill |
356,185,571.87 |
| Long-Term Deferred and Prepaid Expenses |
8,161,845.85 |
| Deferred Income Tax Assets |
39,251,139.56 |
| Other Non-Current Assets |
27,336,056.62 |
| Sub-Total of Non-Current Assets |
2,247,996,178.25 |
| Total Assets |
5,004,414,338.77 |
| Short-Term Loans |
277,612,417.54 |
| Trading Financial liabilities |
5,635,724.67 |
| Notes Payable |
131,693,967.22 |
| Accounts Payable |
209,978,761.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,892,907.70 |
| Taxes Payable |
9,387,266.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,643,288.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,747,085.21 |
| Other Current Liabilities |
2,876,754.89 |
| Sub-Total of Current Liabilities |
757,364,339.56 |
| Long-term Loans |
396,740,667.16 |
| Bonds Payable |
1,056,394,682.28 |
| Long-Term Accounts Payable |
450,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,706,774.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,526,012,974.02 |
| Total Liabilities |
2,283,377,313.58 |
| Paid-In Capital(Or Share Stock) |
199,664,344.00 |
| Capital Surplus |
1,081,769,541.41 |
| Surplus Reserve |
96,995,628.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,222,122,512.71 |
| Minority Stockholder's Interest |
-2.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,721,037,027.73 |
| Owner's Equity（Stockholder's Equity） |
2,721,037,025.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,004,414,338.77 |
